Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
Regorafenib
Regorafenib is an orally active multi-kinase inhibitor targeting angiogenic (VEGFR, TIE-2), stromal (PDGFR-β) and oncogenic (RAF, RET and c-KIT) receptor tyrosine kinases, with IC50s of 17, 40 and 69 nM for c-KIT, VEGFR2, B-Raf, respectively.
Catalog NO: CT-REGO
Synonym: BAY 73-4506
CAS NO: 755037-03-7
Mol. Formula: C21H15ClF4N4O3 ∙ H2O
MW: 500.83
** The product Regorafenib is being offered as a monohydrate,* the clinical formulation format, validated by a spot-on Quantitative Elemental Analysis, made for in vivo studies. Bulk Stock!!! Prompt.